Back
Seres Therapeutics Stock Price Chart
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
30
MCRB
Seres Therapeutics
Last Price:
0.74
Seasonality Move:
-11.95%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!- The current trend is relatively stagnant and MCRB is experiencing slight selling pressure.
Seres Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.64 | Buy |
| 20-day SMA: | 0.7 | Buy |
| 50-day SMA: | 0.86 | Sell |
| 200-day SMA: | 1.89 | Sell |
| 8-day EMA: | 0.67 | Buy |
| 20-day EMA: | 0.7 | Buy |
| 50-day EMA: | 0.84 | Sell |
| 200-day EMA: | 1.93 | Sell |
Seres Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 49.56 | Sell |
| Chaikin Money Flow: | -1434205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.65 - 0.79) | Buy |
| Bollinger Bands (100): | (0.79 - 1.25) | Sell |
Seres Therapeutics Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Seres Therapeutics Stock
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.73 while MCRB 8-day simple moving average is 0.64, which is a Buy signal.
- The stock price of MCRB is 0.73 while Seres Therapeutics 20-day SMA is 0.70, which makes it a Buy.
- Seres Therapeutics 50-day simple moving average is 0.86 while MCRB share price is 0.73, making it a Sell technically.
- MCRB stock price is 0.73 and Seres Therapeutics 200-day simple moving average is 1.89, creating a Sell signal.
MCRB Technical Analysis vs Fundamental Analysis
Sell
30
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy or a Sell?
-
Seres Therapeutics stock is rated a Sell
The current Seres Therapeutics [MCRB] share price is $0.73. The Score for MCRB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Seres Therapeutics Stock Info
Market Cap:
110.16M
Price in USD:
0.73
Share Volume:
5.81M
Seres Therapeutics 52-Week Range
52-Week High:
6.65
52-Week Low:
0.54
Sell
30
Seres Therapeutics (MCRB)
is a Sell
Seres Therapeutics Share Price Forecast
-
What is the Seres Therapeutics stock price today?
The Seres Therapeutics stock price is 0.73 USD today. -
Will MCRB stock go up or go down?
Seres Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Seres Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seres Therapeutics is overvalued.
Is Seres Therapeutics Stock a Buy?
- Seres Therapeutics share price is 0.73 while MCRB 8-day exponential moving average is 0.67, which is a Buy signal.
- The stock price of MCRB is 0.73 while Seres Therapeutics 20-day EMA is 0.70, which makes it a Buy.
- Seres Therapeutics 50-day exponential moving average is 0.84 while MCRB share price is 0.73, making it a Sell technically.
- MCRB stock price is 0.73 and Seres Therapeutics 200-day simple moving average is 1.93, creating a Sell signal.
Fundamental Analysis of Seres Therapeutics
Is Seres Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.23 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.30 per share.
Technical Analysis of Seres Therapeutics
Should I short Seres Therapeutics stock?
- MCRB Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Seres Therapeutics is a Sell
- Seres Therapeutics Relative Strength Index (RSI) is 49.56, which suggest Seres Therapeutics is oversold
- The Bollinger Bands (25) for Seres Therapeutics is (0.65 - 0.79), which suggest Seres Therapeutics is a Sell
- The Bollinger Bands (100) for Seres Therapeutics is (0.79 - 1.25), which suggest Seres Therapeutics is a Sell
* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.